Intake of isoflavone and lignan phytoestrogens and associated demographic and lifestyle factors in older Australian women

Asia Pacific Journal of Clinical Nutrition

Volumn 19, Issue 4, 2010, Pages 540-549

  Hanna, Katherine L ^a   O'Neill, Sheila ^b,c   Lyons Wall, Philippa M ^d  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Isoflavones; Life style; Lignans; Phytoestrogens; Socio demographic

Indexed keywords

ISOFLAVONE DERIVATIVE; LIGNAN; PHYTOESTROGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIET; DIET SUPPLEMENTATION; DRINKING BEHAVIOR; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; HUMAN; LIFESTYLE; LONGITUDINAL STUDY; METHODOLOGY; MIDDLE AGED; MOTOR ACTIVITY; SMOKING; SOCIOECONOMICS; STATISTICS;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL DRINKING; AUSTRALIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIET; DIETARY SUPPLEMENTS; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; HUMANS; ISOFLAVONES; LIFE STYLE; LIGNANS; LONGITUDINAL STUDIES; MIDDLE AGED; MOTOR ACTIVITY; PHYTOESTROGENS; SMOKING; SOCIOECONOMIC FACTORS;

EID: 78751505388     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Dennison E, Yoshimura N, Hashimoto T, Cooper C. Bone loss in Great Britain and Japan: a comparative longitudinal study. Bone. 1998;23:379-82.
2. Kita T. Coronary heart disease risk in Japan - an East/West divide?. Eur Heart J Suppl. 2004;6:A8-A11.
3. Melby M, Lock M, Kaufert P. Culture and symptom reporting at menopause. Human Reproduct Update. 2005;11:495-512.
4. Somekawa N, Chiguchi M, Ishibashi T, Aso P. Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese Women. Obstet Gynaecol. 2001;97:109-15.
5. Baker M. Endocrine activity of plant-derived compounds: an evolutionary perspective. Proc Soc Exp Biol Med. 1995;208:131-8.
6. Kuiper G, Gustafsson J. The novel estrogen receptor- beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Letters. 1997; 410:87-90.
7. Choi M, Rhee K. Production and processing of soybeans and nutrition and safety of isoflavone and other soy products for human health. J Med Food. 2006;9:1-10.
8. Thompson L, Robb P, Serraino M, Cheung F. Mammalian lignan production from various foods. Nutr Cancer. 1991;16: 43-52.
9. Khoo S, O'Neill S, Travers C, Oldenburg B. Age-related changes relevant to health in women: design, recruitment, and retention strategies for the longitudinal assessment of women (LAW) study. J Women's Health. 2008;17:135-46.
10. United States Department of Agriculture-IOWA State University. USDA-IOWA State University Database on the Isoflavone Content of Foods, Release 1999/1/1 [cited 2001/11/10]; Available from: http://www.nal.usda.gov/fnic/foodcomp/data/isoflav/isoflav.html.
11. King R, Bignell C. Concentrations of isoflavone phytoestrogens and their glucosides in Australian soya beans and soya foods. Aust J Nutr Diet. 2000;57:70-8.
12. Hutabarat L, Greenfield H, Mulholland M. Isoflavones and coumestrol in soybeans and soybean products from Australia and Indonesia. J Food Comp Anal. 2001;14:43-58.
13. Hirvensalo M, Lintunen T, Rantanen T. The continuity of physical activity: a retrospective and prospective study among older people. Scand J Med Sci Sports. 2000;10:37-41.
14. Australian Bureau of Statistics. Australian Standard Classification of Occupations. 2nd Edition ed. Canberra; 1997.
15. Commonwealth of Australia. Population Characteristics. In: Women in Australia 2004. Canberra: Department of Fami-lies Housing, Community Services and Indigenous Affairs. 2004; pp.1-6.
16. McLennan W, Podger A. National Nutrition Survey: Nutrient Intakes and Physical Measurements, Australia, 1995. Canberra: Australian Bureau of Statistics, Commonwealth Department of Health and Aged Care, Commonwealth of Australia; 1998.
17. Bhakta D, Higgins C, Sevak L, Mangtani P, Adlercreutz H, McMichael A, dos Santos Silva I. Phyto-oestrogen intake and plasma concentrations in South Asian and native British women resident in England. Br J Nutr. 2006;95:1150-8.
18. Cotterchio M, Boucher B, Kreiger N, Mills C, Thompson L. Dietary phytoestrogen intake-lignans and isoflavones-and breast cancer risk (Canada). Cancer Causes Control. 2008; 19:259-72.
19. de Kleijn M, van der Schouw Y, Wilson P, Adlercreutz H. Intake of dietary phytoestrogens is low in postmenopausal women in the United States: The Framingham Study. J Nutr. 2001;131:1826-32.
20. French R, Thompson L, Hawker G. Validation of a phytoestrogen food frequency questionnaire with urinary concentrations of isoflavones and lignan metabolites in premenopausal women. J Am Coll Nutr. 2007;26:76-82.
21. Greendale G, Fitzgerald G, Huang M, Sternfeld B, Gold E, Seeman T, Sherman S, Sowers M. Dietary soy isoflavones and bone mineral density: results from the study of women's health across the nation. Am J Epidemiol. 2002;155:746-54.
22. Mulligan A, Welch A, McTaggart A, Bhaniani A, Bingham S. Intakes and sources of soya foods and isoflavones in a UK population cohort study (EPIC-Norfolk). Eur J Clin Nutr. 2007;61:248-54.
23. Atkinson C, Skor H, Fitzgibbons E, Scholes D, Chen C, Wahala K, Schwartz S, Lampe J. Overnight urinary isoflavone excretion in a population of women living in the United States, and its relationship to isoflavone intake. Cancer Epidemiol Biomarkers Prev. 2002;11:253-60.
24. van Erp-Baart M, Brants H, Kiely M, Mulligan A, Turrini A, Sermoneta C, Kilkkinen A, Valsta L. Isoflavone intake in four different European countries: the VENUS approach. British Journal of Nutrition. 2003;89(Suppl 1):S25-S30.
25. Frankenfeld C, Patterson R, Horner N, Neuhouser M, Skor H, Kalhorn T, Howald W, Lampe J. Validation of a soy food-frequency questionnaire and evaluation of correlates of plasma isoflavone concentrations in postmenopausal women. Am J Clin Nutr. 2003;77:674-80.
26. Horn-Ross P, Barnes S, Lee V, Collins C, Reynolds P, Lee M, et al. Reliability and validity of an assesssment of usual phytoestrogen consumption (United States). Cancer Causes Control. 2006;17:85-93.
27. Seow A, Shi C, Franke A, Hankin J, Lee H, Yu M. Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore. Cancer Epidemiol Biomarkers Prev. 1998;7:135-40.
28. Chen Z, Zheng W, Custer L, Dai Q, Shu X, Jin F, Franke A. Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr Cancer. 1999;33:82-7.
29. Arai Y, Uehara M, Sato Y, Kimira M, Eboshida A, Adlercreutz H, Watanabe S. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol. 2000;10:127-35.
30. Ho S, Woo J, Leung S, Sham A, Lam T, Janus E. Intake of soy products is associated with better plasma lipid profiles in the Hong Kong Chinese population. J Nutr. 2000;130: 2590-3.
31. Kim J, Kwon C. Estimated dietary isoflavone intake of Korean population based on National Nutrition Survey. Nutr Res. 2001;21:947-53.
32. Yamamoto S, Sobue T, Sasaki S, Kobayashi M, Arai Y, Uehara M, et al. Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a Japanese population in comparison with dietary records and blood and urine isoflavones. J Nutr. 2001;131:2741-7.
33. Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K. Soy product intake and serum isoflavonoid and estradiol concentrations in relation to bone mineral density in postmenopausal Japanese women. Osteoporosis Int. 2002; 13:200-4.
34. Guthrie J, Ball M, Murkies A, Dennerstein L. Dietary phytoestrogen intake in mid-life Australian-born women: relationship to health variables. Climacteric. 2000;3:254-61.
35. Milder I, Feskens E, Arts I, Bas Bueno de Mesquita H, Hollman P, Kromhout D. Intake of the plant lignans secoisolariciresinol, matairesinol, lariciresinol and pinoresinol in Dutch men and women. J Nutr. 2005;135:1202-7.
36. Hedelin M, Lof M, Olsson M, Adlercreutz H, Sandin S, Weiderpass E. Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. J Nutr. 2008;138:938-45.
37. Liggins J, Bluck L, Runswick S, Atkinson C, Coward W, Bingham S. Daidzein and genistein content of vegetables. Br J Nutr. 2000;84:717-25.
38. Lampe J, Gustafson D, Hutchins A, Martini M, Li S, Wahala K, Grandits G, Potter J, Slavin J. Urinary isoflavonoid and lignan excretion on a Western diet: relation to soy, vegetable, and fruit intake. Cancer Epidemiol Biomarkers Prev. 1999;8:699-707.
39. Schryver T, Smith C, Wall M. Self-identities and BMI of Minnesotan soy consumers and non-consumers. Obesity. 2007;15:1101-6.
40. Wenrich T, Cason K. Consumption and perceptions of soy among low-income adults. J Nutr Educ Behav. 2004;36:140-5.
41. Custer L, Dai Q, Shu X, Jin F, Franke A. Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women living in Shanghai. Nutr Cancer. 1999;33:82-7.
42. Keinan-Boker L, Peeters P, Mulligan A, Navarro C, Slimani N, Mattison I, et al. Soy product consumption in 10 European countries: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr. 2002;5:1217-26.
43. Stofan J, DiPietro L, Davis O, Kohl H, Blair S. Physical activity patterns associated with cardiorespiratory fitness and reduced mortality rate: the Aerobics Center Longitudinal Study. Am J Public Health. 1998;88:1807-13.
44. Kelley G, Kelley K, Tran Z. Exercise and lumbar spine bone mineral density in postmenopausal women: a meta-analysis of individual patient data. J Gerontol A Biol Sci Med Sci. 2002;57A:M599-M604.
45. Clarkson T, Anthony M. Phytoestrogens and coronary heart disease. Baillieres Clin Endocrinol Metab. 1998;12:589-604.
46. Teede H, Dalais F, Kotsopoulos D, Liang Y, Davis S, McGrath B. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab. 2001;86:3053-60.
47. Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res. 2002;17:1904-12.
48. Garrido A, De la Maza M, Hirsch S, Valladares L. Soy isoflavones affect platelet thromboxane A2 receptor density but not plasma lipids in menopausal women. Maturitas. 2006;54:270-6.
49. Turrell G, Mathers C. Socioeconomic status and health in Australia. Med J Aust. 2000;172:434-8.
50. Baines S, Powers J, Brown W. How does the health and well-being of young Australian vegetarian and semi-vegetarian women compare with non-vegetarians? Public Health Nutr. 2007;10:436-42.
51. Worsley A, Wahlqvist M, Dalais F, Savige G. Characteristics of soy bread users and their beliefs about soy products. Asia Pacific J Clin Nutr. 2002;11:51-5.